Proteomic biomarkers of cardiovascular complications in chronic kidney disease-PROTEOMARK_CKD
项目来源
法(略)科(略)金(略)R(略)
项目主持人
未(略)
项目受资助机构
未(略)
立项年度
2(略)
立项时间
未(略)
项目编号
A(略)1(略)E(略)0(略)
项目级别
国(略)
研究期限
未(略) (略)
受资助金额
4(略)1(略)0(略)
学科
V(略)s(略)é(略) (略)n(略)r(略)
学科代码
未(略)
基金类别
P(略)e(略)f(略)n(略)
关键词
未(略)
参与者
M(略)i(略) (略)d(略)S(略)
参与机构
C(略) (略)T(略)D(略)E(略)R(略) (略)É(略)É(略)L(略)E(略) (略)T(略)E(略)O(略)A(略)N(略)n(略)m(略)s(略)u(略)a(略)n(略)d(略)a(略)n(略)e(略)e(略) (略)h(略)h(略)é(略)a(略)I(略);(略)d(略)S(略)
项目标书摘要:Su(略)mmary:CKD(略)affecting(略)he adult (略)and 30%or(略)70 years (略)iovascula(略)VD)is the(略)use of de(略)patients (略)ly increa(略) kidney f(略)lines up (略)mes highe(略)age renal(略)RD)than i(略)al popula(略) mainly a(略)ith two t(略):accelera(略)clerosis (略)c CKD-rel(略)cluding a(略)osis and (略)ormalitie(略)ventricul(略)phy and d(略)sfunction(略)assessmen(略)tly based(略)ramingham(略) and trad(略)k factors(略)es,hypert(略)ipidemia,(略)),which u(略)e CKD-rel(略)plication(略)l CKD-rel(略)s called (略)ns may am(略)is predic(略) patients(略) front of(略)licity of(略)unknown u(略)s,global (略)h as prot(略)ecessary (略)and to ex(略)issue.The(略)ropose to(略)hose obse(略)d to vali(略)velop mol(略)iles pred(略)omplicati(略) main obj(略)ROTEOMARK(略)D progres(略)e seconda(略)e)in the (略) CKD-REIN(略)e cohort.(略)REIN(Chro(略)Disease-R(略)iology an(略)on Networ(略)e prospec(略) study ca(略)n 40 neph(略)atient fa(略)tionally (略)ive with (略)geography(略) or priva(略)atus.From(略)through M(略)033 adult(略)18 years)(略)te(stage (略)in 45-59 (略) m2)or ad(略)e 4,eGFR (略)n/1.73 m2(略)t prior c(略)ysis or k(略)plantatio(略)rmed cons(略)icipate i(略) and were(略)uring a r(略)rology vi(略)e patient(略)events an(略)ll be col(略) baseline(略)cember 31(略)is time,a(略)atients w(略)mpleted 3(略)w-up.For (略)vascular (略)er fatal (略)l,clinica(略)associate(略)ed to doc(略)s by up-l(略)cal or de(略) in the C(略)ormation (略)ary codin(略)al events(略) consider(略)project w(略)ormed by (略) who will(略)t CV even(略)iciently (略)for adjud(略)eline bio(略)pling for(略)oteome an(略) be avail(略) biobank.(略) a case-c(略)n to sele(略)ants for (略) proteome(略)n such a (略)incident (略)fined abo(略) period f(略)e through(略)1,2018 an(略)sample of(略)l populat(略)line are (略)e PROTEOM(略)sortium i(略)of two hi(略)mentary t(略)ing clini(略)ssy,INSER(略)idemiolog(略)istical(B(略)engel,and(略)ger INSER(略)inical pr(略)ost Schan(略) U1048)an(略)atic(Juli(略)erm U1048(略)and opera(略)city whic(略)pillars o(略)ct.PROTEO(略)ll identi(略)date mole(略)tures tha(略)atifying (略)s at risk(略)plication(略)ing estab(略)ical char(略) with pro(略)iles deri(略)asma and (略)cting the(略) pathogen(略)s.Once va(略)se biomar(略)e introdu(略)ical prac(略)esent pro(略)ignifican(略) our unde(略)f the mec(略)CKD assoc(略)nd CKD pr(略)he valida(略) related (略) lead to (略)ry of new(略)ological (略)d allow a(略)enomics"a(略)ociating (略)uided tre(略)tegies an(略)lly targe(略)ological (略)then to b(略) patients(略)r progres(略)s.
- (略)
